Pregnancy and life after preimplantation genetic diagnosis of Smith-Lemli-Opitz syndrome
Objective
To use preimplantation genetic diagnosis to achieve Smith-Lemli-Opitz syndrome -free pregnancies in two couples at high risk of producing an affected child.
Design
Case report.
Setting
A private IVF unit.
Patient(s)
Two couples carrying the W151X mutation in the DHCR7 gene.
Intervention(s)
Removal and testing for the W151X mutation in blastomeres from embryos after standard IVF.
Main Outcome Measure(s)
DNA analysis of blastomeres indicating whether corresponding embryos were mutation-free, for the purpose of transferring only unaffected embryos.
Result(s)
Delivery of healthy children without the W151X mutation in the DHCR7 gene.
Conclusion(s)
This is the first report of preimplantation genetic diagnosis for Smith-Lemli-Opitz syndrome, allowing transfer of mutation-free embryos and successful pregnancies.
Key Words: Preimplantation genetic diagnosis, Smith-Lemli-Opitz syndrome, nested PCR, W151X mutation in the 3 beta-hydroxysterol Delta(7)-reductase gene
To access this article, please choose from the options below
J.L. has nothing to disclose. K.L. has nothing to disclose. A.B. has nothing to disclose. Z.S. has nothing to disclose. K.R. has nothing to disclose.
PII: S0015-0282(08)00586-4
doi:10.1016/j.fertnstert.2008.03.015
© 2008 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

